Skip to main content

Merck

2022 Breast Cancer Guide to Patient Support Services

Merck Helps/Merck Access Program

Merck Helps
800-727-5400
Merck Access Program
855-257-3932

Merck Helps offers a full suite of support services, including the Merck Patient Assistance Program, the Merck Access Program, and the Merck Co-pay Assistance Program.

A list of Merck breast cancer drugs and their patient support programs is provided in the Table.

Merck Helps

Merck Patient Assistance Program

This private and confidential program provides certain products free of charge for up to 1 year to eligible individuals, primarily the uninsured, who could otherwise not afford needed Merck medicines. Patients may be eligible for assistance if they:

  • Are legal residents of the United States or its territories
  • Have no pharmaceutical insurance coverage (patients who do not meet the insurance criteria may still qualify for the Merck Patient Assistance Program if they attest that they have special circumstances of financial and medical hardship, and the income meets the program criteria)
  • Meet specified financial criteria and cannot afford to pay for medication
  • Have a physician/prescriber who has determined that a Merck product may be appropriate for treating their disease.

Click here to enroll your patient in the Merck Patient Assistance Program, and select the prescribed drug from the menu.

Merck Access Program

This program provides eligible patients who have been prescribed Keytruda with access and support services, including insurance coverage and benefits investigations, prior authorizations, and appeals; reimbursement; copay assistance for Keytruda; as well as referrals to the Merck Patient Assistance Program.

Merck Co-pay Assistance Program

Some patients may also be eligible for copay assistance. This program may be available to patients who:

  • Have private health insurance that provides coverage for Keytruda
  • Have been prescribed Keytruda for an FDA-approved indication
  • Are residents of the United States or Puerto Rico
  • Who meet certain financial requirements.

Click here to enroll your patient in the Merck Access Program, including the Merck Co-pay Assistance Program.

TABLE Merck Breast Cancer Drugs

Drugs
Indications
Patient support programs

Drug
Keytruda (pembrolizumab)
Indications
Patient support programs

Drug
Ontruzant (trastuzumab-dttb) for injection
Indications
HER2-overexpressing breast cancer
Patient support programs

Keytruda (pembrolizumab) Indications

High-risk early-stage triple-negative breast cancer in combination with chemotherapy as neoadjuvant treatment, and then continued as a single agent as adjuvant treatment after surgery; locally recurrent unresectable or metastatic triple-negative breast cancer in combination with chemotherapy, where tumors express PD-L1 as determined by an FDA-approved test